WFS opens 25,400 m2 Lyon-Saint Exupery cargo terminal, its second-largest in France

I have handled enough pharma and biotech freight through French gateways to know that when a ground handler the size of WFS opens 25,400 square metres of new capacity in a hub that was already busy, the ripple reaches every shipper who cares about cold chain. SATS-owned WFS has just switched on its new Lyon-Saint Exupery DC1 cargo terminal, and the numbers are worth a closer look before you assume it is just another warehouse.

The scale: 25,400 square metres, making it WFS's second-largest French operation after Paris Charles de Gaulle. That is not a minor satellite shed; it is a flagship-grade facility in France's number-two air-cargo hub, the Cargoport at Lyon. For anyone who has fought for cold capacity at CDG and lost the argument to volume, a major new node matters.

What is inside is the part that should interest healthcare and pharma shippers specifically. The site brings 4,400 square metres of cold rooms, real temperature-controlled space, not a few refrigerated corners, and 36 door docks, five of them dedicated to pallet transfers. Cold room of that size in a regional hub is the kind of infrastructure that lets a lane diversify away from the Paris bottleneck, and diversification is exactly what tight CDG capacity has been crying out for.

The 380 customer accounts consolidated onto one site tell you something about WFS's intent. Pulling that many accounts into a single campus means the handler is betting on Lyon as a genuine alternative gateway, not a spillover lot. For an importer or exporter, account consolidation can mean simpler relationships and one point of contact, but it also means you should be asking whether your existing forwarder or handler already has a presence there.

Let me translate capacity into a planning number, because square metres only matter if they change your lead time or your cost. Suppose you are a pharma shipper currently routing everything through CDG and your cold-throughput there is constrained during peak weeks, pushing confirmations out by, say, three to five days. A new node with 4,400 square metres of cold room and 36 docks does not just add space, it gives you a fallback that, used proactively, can shave those peak-week delays because you are no longer competing only inside the CDG queue.

The five docks dedicated to pallet transfers are a detail worth flagging. In a cold chain, every time a pallet gets rehandled or sits on a dock, you add a temperature-excursion risk and a handling hour. Dedicated transfer docks signal the facility is built for through-movement of unit loads, not just storage, which is what pharma and biotech actually need, goods that keep moving under control, not goods that sit. For high-value vaccine or biologic flows, that design choice is the difference between a viable secondary lane and a pretty warehouse.

For shippers today dependent on CDG, the immediate move is to qualify Lyon as a secondary or balancing gateway before the next peak, not during it. Qualifying means more than knowing the building exists: it means confirming your forwarder holds handling agreements there, that your temperature-validation and GDP paperwork transfer cleanly to a Lyon-based operation, and that your French or European receiver accepts delivery through Lyon rather than insisting on CDG. None of that is hard, but all of it takes the three to four weeks you will not have in a crunch.

There is a cost angle too. A new entrant terminal often prices to win volume in its first year, and WFS will want to fill 25,400 square metres and justify the 300-plus jobs the facility sustains. That can mean more competitive handling rates at Lyon versus a saturated CDG, at least while the terminal builds its base. If your margin is thin and your cold handling bill at CDG is a line item you resent, a Lyon quote is worth requesting now, before the incentive pricing firms up.

The over-300-jobs detail is not just a press-line statistic for a shipper, it signals the terminal is a committed, staffed operation, not a shell waiting for demand. A staffed cold facility matters because pharma handling lives or dies on trained people at 2 a.m. when a logger alarm goes off. When you are choosing between a brand-new building and a proven one, staff maturity is the variable; ask WFS or your forwarder how the Lyon cold team is trained and who runs the night shift.

For healthcare and biotech specifically, the opportunity is to spread risk. If your entire French cold inbound runs through one CDG node and that node hits a congestion or weather event, your product is exposed. A new WFS node at Lyon lets you design a two-gateway plan where one backs up the other. That resilience has a cost, but for temperature-sensitive product with a short shelf life, the alternative, a single point of failure, is the more expensive bet.

One pitfall to name: do not assume new and big means ready for your product on day one. A fresh terminal needs its validation records, its calibrated equipment logs, and its staff rhythms before it earns your high-value pharma. I would run a qualification shipment or two, lower-risk product first, through Lyon before moving critical biologics, and watch the temperature trace end to end. Trust, in cold chain, is built on traces, not brochures.

The reverse-flow angle: if you export French or European pharma or biotech out via Lyon, this terminal gives you a second exit from the country's number-two cargo hub, which can matter when CDG export capacity is tight around quarter-ends or pharma shipping peaks. Having another exit point is the kind of option you only appreciate when the primary is full, so build the paperwork now while both are calm.

For forwarder selection at Lyon, the question is coverage. Not every forwarder has equal muscle at a new WFS site, and the 380 accounts already on campus tell you some do. Ask your forwarder directly whether they are among the on-site accounts, what their handling rates look like at Lyon versus CDG, and whether they can offer a protected cold block there. The answer shapes whether Lyon is a real option for you or just a building you drive past.

Let me put a timeline on it. The terminal is open now, so the window to qualify it cheaply, before competitors crowd in and before the next peak, is the fourth quarter. By mid-November I would want any CDG-dependent pharma shipper to have a Lyon handling agreement in place, a validation shipment done, and a French receiver signed off on Lyon delivery. Waiting until CDG is oversold is the classic mistake.

There is a broader read here for anyone watching European air-cargo geography. Capacity is leaking out of the mega-hubs into strong regional nodes, Lyon's Cargoport being France's number two, and that trend gives shippers options that did not exist five years ago. The shippers who benefit are the ones who qualify the alternative before they need it. The ones who do not will pay spot premiums to discover it mid-crisis.

Pulling this together from someone who has watched a broken cold chain turn a shipment into a write-off: WFS's Lyon terminal is a genuine second node for French pharma and biotech freight, not a press release. Qualify it as a backup now, request a competing Lyon handling quote, run a validation shipment, and get your receiver comfortable with Lyon delivery. The capacity is real; your use of it is a choice you make before the next peak, not during it.

Put Lyon in its geographic context, because location is why this terminal matters beyond the square metres. Lyon sits at the heart of a strong European road and rail feeder network, and the Cargoport has been building as France's number-two air-cargo hub precisely because it offers an alternative to the Paris congestion that pharma and biotech shippers keep hitting. A cold node here is not just spare capacity, it is capacity that can reach your final European destination without funnelling through CDG.

Think about the surrounding industry. The Lyon region and wider Rhone-Alpes area host a dense cluster of healthcare, pharmaceutical and biotech manufacturers, and a 4,400 square metre cold room on their doorstep changes the maths for how they route outbound and inbound. If you are one of those manufacturers, or you serve them, this terminal is worth a site visit this quarter, not a footnote in someone else's press release.

Compare it to the other French regional nodes before you commit. Marseille, Toulouse and others have cargo capability too, and the right fallback for you depends on where your receivers sit and which carriers serve the lane. Lyon's advantage is the WFS scale and the cold room size, but a shipper in the south of France may find a closer node cheaper to reach. Do the comparison on your own freight map rather than assuming Lyon is the answer by default.

Look at the throughput design. Thirty-six door docks, five dedicated to pallet transfers, signal a facility built for movement rather than storage, and for pharma that distinction is the whole point. A cold chain that keeps unit loads flowing under control protects product integrity better than one that parks pallets while it waits for a slot. When you qualify the site, watch an actual transfer, not just the brochure, and judge whether the rhythm matches your service need.

On the staffing point, ask the hard questions about night cover. Pharma does not stop at 5 p.m., and a cold alarm at 2 a.m. is only useful if a trained person responds. The 300-plus jobs suggest a committed operation, but commitment is proven in the small hours, so ask WFS or your forwarder who runs the Lyon night shift, what their cold escalation looks like, and whether a logger alarm pages a qualified person directly. That answer tells you more than the building tour.

And one more thing worth watching is the WFS and SATS strategy, because a new terminal is rarely a one-off. SATS has been expanding its ground-handling footprint across Europe, and a flagship Lyon site signals intent to compete for high-value flows, not just volume. For a shipper, that means the incentive pricing and the service attention are likely to last longer than a single opening quarter, so building your presence there early can lock in both rate and relationship before the rest of the market notices.

A practical note on the quotation process. New-terminal incentive pricing is real but not forever, so request the Lyon handling quote in writing this quarter and pin the validity window. A rate you do not lock is a rate you lose when the terminal fills, and the 300-plus jobs the facility sustains mean WFS has every reason to firm up pricing once the base is built. The early ask is the cheap ask.

Consider the road feeder from Lyon to your real destination. Lyon's value is not just the airport but the highway and rail links that reach southern France, Switzerland, Italy and beyond without touching Paris. If your final delivery is outside the Ile-de-France, a Lyon routing can be shorter in total transit even before you count the CDG congestion you avoided. Map the door-to-door time, not just the flight, when you compare the two gateways.

Do not over-rotate in panic. Adding Lyon as a backup is sensible; declaring CDG redundant is not. Keep the majority of your volume where your relationships and your proof are deepest, and use Lyon for the peak-week overflow and the resilience case. A second node earns its place by absorbing the worst weeks, not by replacing a hub you know cold.

Watch the validation evidence. When you run those low-risk trial shipments, collect the temperature traces, the handling timestamps and the customs entry records, and keep them as your qualification file. The next time a critical biologic is due and someone questions whether Lyon is ready, that file is your answer, not a promise. In cold chain, evidence beats assertion every time.

And think about the people pipeline beyond opening. A new facility staffing up will have a learning curve, and the 300 jobs include people new to this specific operation. In the first months, favour your lower-risk product through Lyon and let the team find its rhythm before you route anything that cannot tolerate a stumble. Patience in the first quarter is cheaper than a write-off later.

Think about the signal this sends to your contingency planning beyond France. If the busiest hubs keep spawning strong regional nodes, the shipper who builds optionality, a backup gateway here, a spare lane there, is the one who absorbs the next disruption without a fire drill. WFS opening 25,400 square metres at Lyon is one data point in a trend, and the trend favours the prepared. Treat this terminal as a prompt to map your alternatives across every hub you depend on.

And do not wait for a crisis to validate Lyon. The cheapest time to discover a gateway's weaknesses is in calm weather, on a low-risk shipment, with no deadline breathing down your neck. Run the trial, build the file, sign the receiver, and then let the terminal sit as insurance. When CDG clogs next peak, you will be glad the option exists and that you already know how to use it.

Let me speak to the risk-averse shipper who distrusts anything new. A fresh terminal is a known unknown, and your instinct to wait is not wrong, it is just incomplete. The way to wait safely is to qualify now and use later, running trials on low-risk goods while the terminal is hungry for volume and eager to prove itself, so that when you finally trust it with critical product, the evidence is already in your file. Caution and preparation are not opposites.

Think about your insurance and liability wording too. A new cold node changes where your goods sit and who handles them, and your cargo policy should name the actual handlers and locations, not a generic gateway. If Lyon becomes part of your routing, confirm the underwriter covers it and that the cold-chain excursion clause applies at that site, because a gap in coverage is the kind of surprise you find only after a loss.

And give your receiver the heads-up now. The French or European customer who expects delivery through CDG may not be set up to receive through Lyon, with its own customs entry, its own delivery window, and its own proof requirements. A five-minute call this month to confirm they can accept Lyon saves a confused driver and a missed appointment next peak. The best gateway in the world is useless if the other end is not ready.

Let me run a number, flagged as an assumption so nobody quotes it as fact. Suppose you are a pharma shipper sending 20 tonnes a month out of the Lyon region, and today every kilo trucks 450 kilometres to CDG before it flies. Assume the combined road leg plus handling runs you about 0.60 euros a kilo, and that routing direct through Lyon saves roughly 0.40 euros a kilo once the trucking distance collapses. Twenty tonnes is 20,000 kilos, so that is about 8,000 euros a month, close to a hundred thousand a year, before you count the fewer temperature excursions from shorter road time. Those figures are illustrative — your real saving depends on your rates — but the shape of the math is why regional gateways get built.

Beyond the math, think about what a shorter road leg does to a validated cold chain. Every kilometre a pallet of biologics spends on a truck is time outside the controlled environment you qualified, and every transfer between truck and terminal is a break in the trace you have to defend in an audit. Lyon direct means a shorter unqualified leg and fewer hands, which is exactly what a temperature-mapped, GDP-disciplined flow wants. If your product is a two-to-eight-degree vaccine, the risk you are buying down is not the airfare, it is the road.

There is also a diversion story worth naming. CDG is not losing its crown — it remains the biggest gateway in the country — but not everything that goes through CDG needs to. Regional cargo that was trucked to Paris because there was nowhere else now has somewhere else, and every pallet that routes through Lyon is a pallet of capacity freed at CDG for the flows that genuinely need it. If you are a shipper in the south or southeast of France — Lyon, Grenoble, Saint-Etienne, down toward the Mediterranean corridor — the sensible exercise this quarter is to map which of your lanes actually need CDG and which were only there by default. For the second group, Lyon is now the default. That is how a second hub quietly changes a network: not by replacing the big one, but by taking the traffic that never really belonged there.

• Qualify Lyon-Saint Exupery as a secondary or balancing cold gateway by mid-November: confirm your forwarder holds handling agreements there and your GDP paperwork transfers cleanly.
• Request a Lyon handling quote and compare it against your saturated CDG rate; new-terminal incentive pricing may be softer while the site builds its base.
• Run one or two low-risk validation shipments through the new 4,400 m2 cold room before moving critical biologics, and review the temperature trace end to end.
• Confirm your French or European receiver accepts delivery through Lyon rather than insisting on CDG, before peak season.
• Ask your forwarder whether they are among the 380 on-site accounts and can offer a protected cold block at Lyon.
• Build a two-gateway plan so Lyon backs up CDG for French pharma inbound, removing your single-point-of-failure exposure.